Issues concerning access to and reimbursement for the Medicare Hospice benefit. Issues related to regulatory relief. Monitored Medicare Advantage and the hospice benefit. Issues regarding program integrity. Monitored issues regarding telehealth and hospice care. The Hospice Special Focus Program. S. 1845, Expanding Access to Palliative Care Act and issues related to community-based palliative care. Issues concerning hospice surveys. H.R.2872, Further Additional Continuing Appropriations and Other Extensions Act, 2024, H.R.4366, Consolidated Appropriations Act, 2024, and H.R.2882, Further Consolidated Appropriations Act, 2024, as they relate to hospice reimbursement.
Issues related to health care workforce shortages. S. 2243, The Palliative Care and Hospice Education and Training Act (PCHETA).
Duration: May 1, 2022
to
present
General Issues: Medicare/Medicaid , Health Issues , Government Issues
Spending: about $350,000 (But it's complicated. Here's why.)
It can be tricky to figure out how much an organization spent on a particular lobbying engagement. The law only requires lobbyists to report the amount they were paid for federal lobbying each quarter rounded to the nearest $10,000—and if it's less than $3,000 in a given quarter (or less than $13,000 for organizations with in-house lobbyists), they don't have to disclose it at all. Plus, some organizations include spending that doesn’t belong in the report—for instance, money spent lobbying state governments or other legal work.
Agencies lobbied since 2022: U.S. Senate, House of Representatives, Centers For Medicare and Medicaid Services (CMS), Medicare Payment Advisory Commission (MedPAC)
Lobbyists
Lobbyists named here were listed on a filing related to this lobbying engagement. They may not be working on it now. Occasionally, a single lobbyist whose name is spelled two different ways on filings may be represented twice here.
Lobbyist
Covered positions?
Mary Beth Savary Taylor Joint Economic Committee, General Counsel; U.S. Senator Connie Mack, Legislative Assistant
Jeff Choudhry U.S. Rep. Trent Franks, Legislative Director; U.S. Rep. Trent Franks, Legislative Assistant / Staff Assistant; House Small Business Committee, Intern
Brett Baker U.S. Senate Committee on Finance (Senators Crapo, Grassley, and Hatch)-Deputy Health Policy Director; Health Policy Dir.; Senior Policy Advsr; Policy Advisor. U.S. House of Representatives Committee on Ways and Means (Reps. Camp and Ryan) Prof. Staff
Disclosures Filed
Once a lobbying engagement begins, the lobbyist or firm is required to file updates four times a year. Those updates sometimes change which lobbyists are involved or add new issues being discussed. When lobbyists stop working for a client, the firm is also supposed to file a report disclosing the end of the relationship.
1st Quarter, 2024
In Q1, THE NICKLES GROUP, LLC lobbied for VITAS Healthcare , earning $50,000. The report was filed on April 22.
Original Filing: 301572960.xml
Lobbying Issues
Issues concerning access to and reimbursement for the Medicare Hospice benefit. Issues related to regulatory relief. Monitored Medicare Advantage and the hospice benefit. Issues regarding program integrity. Monitored issues regarding telehealth and hospice care. The Hospice Special Focus Program. S. 1845, Expanding Access to Palliative Care Act and issues related to community-based palliative care. Issues concerning hospice surveys. H.R.2872, Further Additional Continuing Appropriations and Other Extensions Act, 2024, H.R.4366, Consolidated Appropriations Act, 2024, and H.R.2882, Further Consolidated Appropriations Act, 2024, as they relate to hospice reimbursement.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to health care workforce shortages. S. 2243, The Palliative Care and Hospice Education and Training Act (PCHETA).
Agencies Lobbied
U.S. Senate
4th Quarter, 2023
In Q4, THE NICKLES GROUP, LLC lobbied for VITAS Healthcare , earning $50,000. The report was filed on Jan. 22.
Original Filing: 301536348.xml
Lobbying Issues
Issues concerning access to and reimbursement for the Medicare hospice benefit. Issues related to community based palliative care. Issues related to regulatory relief. Monitored Medicare Advantage and the hospice benefit. Issues regarding program integrity. Monitored issues regarding telehealth and hospice care. The CY24 Home Health Prospective Payment Final Rule and issues involving the hospice Special Focus Program. Issues involving access to hospice services in rural and underserved areas. S. 1845, Expanding Access to Palliative Care Act and issues related to community-based palliative care. Issues concerning hospice surveys. S.3430, Better Mental Health Care, Lower-Cost Drugs, and Extenders Act of 2023, as it relates to hospice reimbursement.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to health care workforce shortages. S. 2243, The Palliative Care and Hospice Education and Training Act (PCHETA).
Agencies Lobbied
U.S. Senate
3rd Quarter, 2023
In Q3, THE NICKLES GROUP, LLC lobbied for VITAS Healthcare , earning $50,000. The report was filed on Oct. 18, 2023.
Original Filing: 301505373.xml
Lobbying Issues
Issues concerning access to and reimbursement for the Medicare hospice benefit. Issues related to community based palliative care. Issues related to regulatory relief. Monitored Medicare Advantage and the hospice benefit. Issues regarding program integrity. Monitored issues regarding telehealth and hospice care. The FY24 Hospice Wage Index Proposed Rule. The CY24 Home Health Prospective Payment Proposed Rule and issues involving the hospice Special Focus Program. Issues involving access to hospice services in rural and underserved areas. S. 1845, Expanding Access to Palliative Care Act and issues related to community-based palliative care.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to health care workforce shortages. S. 2243, The Palliative Care and Hospice Education and Training Act (PCHETA).
Agencies Lobbied
U.S. Senate
2nd Quarter, 2023
In Q2, THE NICKLES GROUP, LLC lobbied for VITAS Healthcare , earning $50,000. The report was filed on July 20, 2023.
Original Filing: 301488655.xml
Lobbying Issues
Issues concerning access to and reimbursement for the Medicare hospice benefit. Issues related to community based palliative care. Issues related to regulatory relief. Monitored Medicare Advantage and the hospice benefit. Issues regarding program integrity. Monitored issues regarding telehealth and hospice care. The FY24 Hospice Wage Index Proposed Rule.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to health care workforce shortages. S. 1845, Expanding Access to Palliative Care Act and issues related to community based palliative care. S. 2243, The Palliative Care and Hospice Education and Training Act (PCHETA).
Agencies Lobbied
U.S. Senate
1st Quarter, 2023
In Q1, THE NICKLES GROUP, LLC lobbied for VITAS Healthcare , earning $40,000. The report was filed on April 18, 2023.
Original Filing: 301455041.xml
Lobbying Issues
Issues concerning access to and reimbursement for the Medicare hospice benefit. Issues related to community based palliative care. Issues related to regulatory relief. Monitored Medicare Advantage and the hospice benefit. Issues regarding program integrity. Monitored issues regarding telehealth and hospice care.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to health care workforce. Issues concerning workforce training for hospice and palliative care services. Issues related to community based palliative care. Issues regarding the PHE extension.
Agencies Lobbied
U.S. Senate
4th Quarter, 2022
In Q4, THE NICKLES GROUP, LLC lobbied for VITAS Healthcare , earning $40,000. The report was filed on Jan. 19, 2023.
Original Filing: 301435041.xml
Lobbying Issues
Issues concerning access to and reimbursement for the Medicare hospice benefit. H.R. 2617 (P.L. 117-328), the Consolidated Appropriations Act of 2023 and issues concerning hospice reimbursement, bereavement care, and telehealth. Medicare sequestration relief. Issues related to community based palliative care and S. 2565, Expanding Access to Palliative Care Act. Issues related to regulatory relief. Monitored Medicare Advantage and the hospice benefit. Issues related to COVID. H.R. 8505, To amend Title XVIII of the Social Security Act to permit the use of telehealth for purposes of recertification of eligibility for hospice care; H.R. 4040, Advancing Telehealth Beyond Covid-19 Act of 2021; S. 368 / H.R. 1332, the Telehealth Modernization Act; S. 1512 / H.R. 2903, The Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) Act, as they relate to use of telehealth in the certification of a beneficiary for the hospice benefit. Issues regarding program integrity. Issues regarding bereavement care.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to health care workforce including H.R. 2255 / S. 1024, Healthcare Workforce Resilience Act and S. 2890, the Provider Training in Palliative Care Act. S. 4260, Palliative Care and Hospice Education & Training Act (PCHETA). H.R. 2617 (P.L. 117-328), the Consolidated Appropriations Act of 2023, as it relates to PCHETA and bereavement care. Issues related to community based palliative care. H.R. 9109, The Grief Resilience Investment and Education Fund (GRIEF) Act.
Agencies Lobbied
U.S. Senate
3rd Quarter, 2022
In Q3, THE NICKLES GROUP, LLC lobbied for VITAS Healthcare , earning $40,000. The report was filed on Oct. 18, 2022.
Original Filing: 301407211.xml
Lobbying Issues
Issues concerning access and reimbursement to the Medicare hospice benefit. Issues related to community based palliative care and advanced care illness management. S. 2565, Expanding Access to Palliative Care Act. Issues related to regulatory relief. Issues concerning Medicare Advantage and the hospice benefit. Issues related to COVID. H.R. 4040, Advancing Telehealth Beyond Covid-19 Act of 2021, S. 368 / H.R. 1332, the Telehealth Modernization Act, as they relate to use of telehealth in the certification of a beneficiary for the hospice benefit. S. 1512 / H.R. 2903, The Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) Act. Medicare sequestration relief. Issues regarding program integrity. Monitored H.R. 5376 (P.L. 117-169), the Inflation Reduction Act, as it relates to palliative care. The FY 2023 Proposed Hospice Wage Rule, as it relates to reimbursement for the hospice Medicare benefit.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to health care workforce including Healthcare Workforce Resilience Act (H.R. 2255 / S. 1024) and the Provider Training in Palliative Care Act (S. 2890). S. 4260, Palliative Care and Hospice Education & Training Act. Issues related to community based palliative care and advanced care illness management. H.R. 9109, The Grief Resilience Investment and Education Fund (GRIEF) Act and issues regarding bereavement care.
Agencies Lobbied
U.S. Senate
2nd Quarter, 2022
In Q2, THE NICKLES GROUP, LLC lobbied for VITAS Healthcare , earning $30,000. The report was filed on July 19, 2022.
Original Filing: 301387783.xml
Lobbying Issues
Issues concerning access to the Medicare hospice benefit. Issues regarding reimbursement for the Medicare hospice benefit. Issues related to community based palliative care and advanced care illness management. Issues related to regulatory relief. Issues concerning Medicare Advantage and the hospice benefit. Issues related to COVID. S. 368 / H.R. 1332, the Telehealth Modernization Act, as it relates to use of telehealth in the certification of a beneficiary for the hospice benefit. S. 1512 / H.R. 2903, The Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) Act. Medicare sequestration relief. Monitored implementation of P.L. 117-2, the American Rescue Plan, as it relates to the provider relief fund. Issues regarding program integrity. H.R. 5376, the Build Back Better Act as it relates to palliative care. S. 2565, Expanding Access to Palliative Care Act. The FY 2023 Proposed Hospice Wage Rule.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues related to health care workforce issues including Healthcare Workforce Resilience Act (H.R. 2255 / S. 1024) and the Provider Training in Palliative Care Act (S. 2890). S. 4260, Palliative Care and Hospice Education & Training Act. Issues related to community based palliative care and advanced care illness management.
Agencies Lobbied
U.S. Senate
Lobbying Issues
Issues concerning access to the Medicare hospice benefit. Issues regarding reimbursement for the Medicare hospice benefit. Issues related to community based palliative care and advanced care illness management. Issues related to regulatory relief. Issues concerning Medicare Advantage and the hospice benefit. Issues related to COVID. H.R. 1332, the Telehealth Modernization Act, as it relates to use of telehealth in the certification of a beneficiary for the hospice benefit. H.R. 2903, The Creating Opportunities Now for Necessary and Effective Care Technologies (CONNECT) Act. Medicare sequestration relief. Monitored implementation of P.L. 117-2, the American Rescue Plan, as it relates to the provider relief fund. Issues regarding program integrity. H.R. 5376, the Build Back Better Act as it relates to palliative care. Issues related to health care workforce issues including Healthcare Workforce Resilience Act (H.R. 2255). Issues related to community based palliative care and advanced care illness management. The FY 2023 Proposed Hospice Wage Rule.
Agencies Lobbied
U.S. House of Representatives
Source: Clerk of the U.S. House of Representatives and Secretary of the Senate
Searching...